Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2012 3
2013 1
2014 1
2015 1
2016 1
2017 3
2018 4
2019 4
2020 5
2021 2
2022 4
2023 2
2024 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

29 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean kalloo a[au] (308 results)?
Cutaneous immune-related adverse events to checkpoint inhibitors.
Malviya N, Tattersall IW, Leventhal J, Alloo A. Malviya N, et al. Among authors: alloo a. Clin Dermatol. 2020 Nov-Dec;38(6):660-678. doi: 10.1016/j.clindermatol.2020.06.011. Epub 2020 Jun 27. Clin Dermatol. 2020. PMID: 33341200 Review.
Defining D-irAEs: consensus-based disease definitions for the diagnosis of dermatologic adverse events from immune checkpoint inhibitor therapy.
Chen ST, Semenov YR, Alloo A, Bach DQ, Betof Warner A, Bougrine A, Burton L, Cappelli LC, Castells M, Cohen J, Dewan AK, Fadden R, Guggina L, Hegde A, Huang V, Johnson DB, Kaffenberger B, Kroshinsky D, Kwatra S, Kwong B, Lacouture ME, Larocca C, Leventhal J, Markova A, McDunn J, Mooradian MJ, Naidoo J, Choi J, Nambudiri V, Nelson CA, Patel AB, Pimkina J, Rine J, Rubin KM, Sauder M, Shaigany S, Shariff A, Sullivan RJ, Zubiri L, Reynolds KL, LeBoeuf NR. Chen ST, et al. Among authors: alloo a. J Immunother Cancer. 2024 Apr 10;12(4):e007675. doi: 10.1136/jitc-2023-007675. J Immunother Cancer. 2024. PMID: 38599660 Free PMC article.
Mucocutaneous toxicities from MEK inhibitors: a scoping review of the literature.
Iriarte C, Yeh JE, Alloo A, Boull C, Carlberg VM, Coughlin CC, Lara-Corrales I, Levy R, Nguyen CV, Oza VS, Patel AB, Rotemberg V, Shah SD, Zheng L, Miller CH, Hlobik M, Daigneault J, Choi JN, Huang JT, Vivar KL. Iriarte C, et al. Among authors: alloo a. Support Care Cancer. 2024 Aug 23;32(9):610. doi: 10.1007/s00520-024-08810-x. Support Care Cancer. 2024. PMID: 39174797 Review.
Ixazomib-induced cutaneous necrotizing vasculitis.
Alloo A, Khosravi H, Granter SR, Jadeja SM, Richardson PG, Castillo JJ, LeBoeuf NR. Alloo A, et al. Support Care Cancer. 2018 Jul;26(7):2247-2250. doi: 10.1007/s00520-018-4052-1. Epub 2018 Feb 1. Support Care Cancer. 2018. PMID: 29392482
Subjective assessments in pyoderma gangrenosum diagnostic frameworks undermine framework agreement.
Nusbaum KB, Boettler M, Korman AM, Alavi A, Alloo A, Dissemond J, French LE, Huang WW, Kolios AGA, Marzano AV, Micheletti RG, Mostaghimi A, Ortega-Loayza AG, Rosenbach M, Schreml S, Tolkachjov SN, Kaffenberger BH. Nusbaum KB, et al. Among authors: alloo a. Int J Dermatol. 2024 Feb;63(2):e67-e69. doi: 10.1111/ijd.16952. Epub 2023 Dec 3. Int J Dermatol. 2024. PMID: 38044552 No abstract available.
Clinical Characteristics, Disease Course, and Outcomes of Patients With Acute Generalized Exanthematous Pustulosis in the US.
Creadore A, Desai S, Alloo A, Dewan AK, Bakhtiar M, Cruz-Diaz C, Femia A, Fox L, Katz KL, Micheletti R, Nelson CA, Ortega-Loayza AG, Patrinely JR Jr, Plovanich M, Rosenbach M, Shaigany S, Shields BE, Saleh JZ, Sharif-Sidi Z, Shinkai K, Smith J, Su C, Wanat KA, Wieser JK, Wright S, Noe MH, Mostaghimi A. Creadore A, et al. Among authors: alloo a. JAMA Dermatol. 2022 Feb 1;158(2):176-183. doi: 10.1001/jamadermatol.2021.5390. JAMA Dermatol. 2022. PMID: 34985493 Free PMC article.
29 results